NCT02666027 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Hung OR, Comeau
L. Incidence of intra-operative cessation of intravenous (iv) fluid administration. Can J Anesth 1998;45:A5.
Janakan G, Ellis H
Dr Thomas Aitchison Latta (c1796-1833): pioneer of intravenous fluid replacement in the treatment of cholera. J Med Biogr. 2013 May;21(2):70-4. doi: 10.1258/jmb.2012.012004.
Matern U, Koneczny S
Safety, hazards and ergonomics in the operating room. Surg Endosc. 2007 Nov;21(11):1965-9. Epub 2007 May 5.
Mendenhall ML, Spain DA
Venous air embolism and pressure infusion devices. J Trauma. 2007 Jul;63(1):246.
Mirski MA, Lele AV, Fitzsimmons L, Toung TJ
Diagnosis and treatment of vascular air embolism. Anesthesiology. 2007 Jan;106(1):164-77. Review.
Pant D, Narani KK, Sood J
Significant air embolism: A possibility even with collapsible intravenous fluid containers when used with rapid infuser system. Indian J Anaesth. 2010 Jan;54(1):49-51. doi: 10.4103/0019-5049.60498.

The Use of the Fluid IV Alert (FIVA) Monitor to Decrease the Incidence of Undetected Empty Intravenous Bag in Dimmed Operating Rooms

Clinical trial NCT02666027 - References